Utsugi T[au] - Search Results

Year	Number of Results
1982	1
1983	1
1984	2
1985	5
1986	6
1987	2
1988	3
1989	3
1990	3
1991	8
1992	5
1993	1
1994	3
1995	2
1996	6
1997	5
1998	8
1999	9
2000	8
2001	7
2002	3
2003	3
2004	6
2005	3
2006	2
2007	5
2008	2
2010	2
2011	4
2012	2
2013	4
2014	4
2015	2
2016	2
2017	1
2018	2
2019	2
2020	2
2021	0

1

Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. Kuro-o M, et al. Among authors: utsugi t. Nature. 1997 Nov 6;390(6655):45-51. doi: 10.1038/36285. Nature. 1997. PMID: 9363890

2

[Laminin, collagen].

Tomono S, Utsugi T, Ito H. Tomono S, et al. Among authors: utsugi t. Nihon Rinsho. 2002 Aug;60 Suppl 8:463-8. Nihon Rinsho. 2002. PMID: 12355791 Review. Japanese. No abstract available.

3

TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.

Tanaka Y, Wada H, Goto R, Osada T, Yamamura K, Fukaya S, Shimizu A, Okubo M, Minamiguchi K, Ikizawa K, Sasaki E, Utsugi T. Tanaka Y, et al. Among authors: utsugi t. Sci Rep. 2020 Oct 14;10(1):17284. doi: 10.1038/s41598-020-74187-6. Sci Rep. 2020. PMID: 33057061 Free PMC article.

4

Identification of dominant T-cell epitopes in the major Japanese cypress pollen allergen Cha o 3.

Osada T, Yamada A, Sasaki E, Utsugi T. Osada T, et al. Among authors: utsugi t. Allergol Int. 2020 Jan;69(1):141-143. doi: 10.1016/j.alit.2019.07.008. Epub 2019 Aug 13. Allergol Int. 2020. PMID: 31420173 Free article. No abstract available.

5

DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.

Byl JA, Cline SD, Utsugi T, Kobunai T, Yamada Y, Osheroff N. Byl JA, et al. Among authors: utsugi t. Biochemistry. 2001 Jan 23;40(3):712-8. doi: 10.1021/bi0021838. Biochemistry. 2001. PMID: 11170388

6

DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.

Byl JA, Fortune JM, Burden DA, Nitiss JL, Utsugi T, Yamada Y, Osheroff N. Byl JA, et al. Among authors: utsugi t. Biochemistry. 1999 Nov 23;38(47):15573-9. doi: 10.1021/bi991791o. Biochemistry. 1999. PMID: 10569941

7

Holographic scattering in an angular-multiplexed hologram on a photopolymer.

Utsugi T. Utsugi T. Appl Opt. 2018 Jan 20;57(3):527-537. doi: 10.1364/AO.57.000527. Appl Opt. 2018. PMID: 29400777

8

DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.

Fortune JM, Velea L, Graves DE, Utsugi T, Yamada Y, Osheroff N. Fortune JM, et al. Among authors: utsugi t. Biochemistry. 1999 Nov 23;38(47):15580-6. doi: 10.1021/bi991792g. Biochemistry. 1999. PMID: 10569942

9

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, Verdaguer J, Santamaria P. Serra P, et al. Among authors: utsugi t. Immunity. 2003 Dec;19(6):877-89. doi: 10.1016/s1074-7613(03)00327-3. Immunity. 2003. PMID: 14670304 Free article.

10

Photocatalytic CO₂ Reduction Using Various Heteroleptic Diimine-Diphosphine Cu(I) Complexes as Photosensitizers.

Yamazaki Y, Onoda T, Ishikawa J, Furukawa S, Tanaka C, Utsugi T, Tsubomura T. Yamazaki Y, et al. Among authors: utsugi t. Front Chem. 2019 Apr 30;7:288. doi: 10.3389/fchem.2019.00288. eCollection 2019. Front Chem. 2019. PMID: 31114784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results